Last week I completed a long journey. I joined Ken Cohen’s very extensive Qigong Teacher Certification program in 2017.
Nikolai Strusberg, MD, discussed other toxicities of proton vs photon breast RT, practice implications, and next steps in ...
The FDA has approved Enspryng (satralizumab-mwge) for thyroid eye disease in adults, offering the first at-home subcutaneous IL-6 receptor antagonist for TED.
Nationwide initiative brings thyroid awareness, health education, targeted TSH screening and referral closer to the community ...
The FDA approved satralizumab-mwge (Enspryng; Genentech) on October 15, 2026, for adults with thyroid eye disease (TED) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results